Health News

Medical Marijuana Inc applauds the New Jersey State Assembly and Senate for having approved “The New Jersey Compassionate Use Medical Marijuana Act” on Monday, January 11, 2010. A804/S119 removes state-wide penalties for possession of up to two ounces of marijuana when a New Jersey licensed Physician recommends it for one of the qualified medical conditions including Aids, Cancer, Multiple Sclerosis and Crohn’s disease among others.

Read more

Filed under: Pharmacy News
Tags: AIDS, cancer, Pharmacy, sclerosis

Related posts

• VBL Therapeutics’ VB-201 candidate delays onset of EAE, shows potential for MS, CNS treatment (0)
  VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis. Read [...]
  
  
• Unique clinical trial addresses important questions about treating AIDS-related cancers (0)
  As the world marks the 30-year anniversary of the first reporting of HIV/AIDS, now comes the realization of a new challenge for people with the incurable disease. For reasons not yet clear, people with HIV face a higher rate of cancers not usually associated with HIV. This increasing rate of "non-AIDS defining cancers" includes lung, [...]
  
  
• Scientists solve 50-year-old thalidomide puzzle (0)
  Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments [...]
  
  
• Research marks new direction to treat Pneumocystis, inflammatory diseases (0)
  A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems. Read more [tags] Pharmacy News [/tags]
  
  
• Profectus BioSciences commences GENEVAX IL-12 phase 1 study for HIV (0)
  Profectus BioSciences, a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, and the AIDS Clinical Trials Group announced today the initiation of a phase 1 study of Profectus' multi-antigen HIV plasmid DNA vaccine administered with various doses of GENEVAX™ interleukin-12 pDNA adjuvant and delivered using the electroporation based TriGrid™delivery [...]